Inactive Instrument

Progressive Care, Inc. Share Price Other OTC

Equities

RXMD

US74332G1085

Drug Retailers

Sales 2022 40.6M 3.2B Sales 2023 49.73M 3.91B Capitalization 19.54M 1.54B
Net income 2022 -6M -472M Net income 2023 -19M -1.5B EV / Sales 2022 0.44 x
Net cash position 2022 3.73M 294M Net cash position 2023 6.23M 491M EV / Sales 2023 0.27 x
P/E ratio 2022
-2.94 x
P/E ratio 2023
-1.33 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 49.62%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 62 12/09/22
Director of Finance/CFO 47 30/06/20
Chief Operating Officer 49 30/04/23
Members of the board TitleAgeSince
Chief Executive Officer 62 12/09/22
Director/Board Member 48 31/07/17
Director/Board Member - 20/12/21
More insiders
Progressive Care, Inc. is a personalized healthcare services and technology provider. The Company operates through two segments: Pharmacy Operations and Third-Party Administration. The Pharmacy Operations segment provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, COVID-19 related diagnostics and vaccinations, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, and contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program. The Third-Party Administration segment provides data management and reporting services to support health care organizations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian and Russian. Through its wholly owned subsidiary, ClearMetrX, it offers data management and reporting services to support health care organizations.
More about the company